The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study
NCT06504420
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Primary Antiphospholipid Syndrome
Interventions
DRUG:
Sirolimus
DRUG:
Placebo
Sponsor
Peking University People's Hospital